The miR-146a rs2910164 C/G polymorphism is associated with telangiectasia in systemic sclerosis

Clinical and Experimental Dermatology

Volumn 38, Issue 1, 2013, Pages 99-100

  Sakoguchi, A ^a   Jinnin, M ^a   Makino, T ^a   Kajihara, I ^a   Makino, K ^a   Honda, N ^a   Nakayama, W ^a   Inoue, K ^a   Fukushima, S ^a   Ihn, H ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICRORNA 146A;

ALLELE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE DURATION; FROZEN SECTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; TELANGIECTASIA;

GENOTYPE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC; TELANGIECTASIS;

EID: 84872866349     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2012.04453.x     Document Type: Letter

References (5)

1. Mishra PJ, Banerjee D, Bertino JR,. MiRSNPs or MiR- polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle 2008; 7: 853-8.
2. Furer V, Greenberg JD, Attur M, et al. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol 2010; 136: 1-15.
3. Nakasa T, Miyaki S, Okubo A, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008; 58: 1284-92.
4. Shah AA, Wigley FM, Hummers LK,. Telangiectases in scleroderma. a potential clinical marker of pulmonary arterial hypertension. J Rheumatol 2010; 37: 98-104.
5. Nazari-Jahantigh M, Wei Y, Schober A,. The role of microRNAs in arterial remodelling. Thromb Haemost 2012; 107: 611-18.